Our primary research interests are directed towards understanding the immunopathogenesis of lung injury and repair. Our future research plans are aimed at understanding:

1) Role of innate immunity in the pathogenesis of fibrotic lung diseases, and nanoparticle delivery systems as therapeutics to treat related disorders;

2) Pathogenesis of abnormal pulmonary vascular remodeling and the development of pulmonary hypertension;

3) Innate Type 2 immune responses in normal pulmonary homeostasis and injury and repair;

4) Novel host genes and cellular pathways modulating respiratory viral infections.

Our long-range research goals are to identify the immune and cellular responses that mediate lung injury and repair responses and to identify specific molecular targets that can be targeted in the treatment of related disorders.